Just over a year after its first-round financing, CRISPR company Locus Biosciences has signed up Johnson & Johnson as its first big pharma partner and pocketed a $20 million upfront fee. While most ...
Locus Biosciences—a clinical-stage biotech developing a new class of CRISPR-based antibacterial drugs—just closed a $35 million financing round with backing from Johnson & Johnson. The $35 million ...
RESEARCH TRIANGLE PARK, N.C., October 28, 2025--(BUSINESS WIRE)--Locus Biosciences, Inc. ("Locus"), a clinical-stage biotechnology company developing precision engineered bacteriophage treatments for ...
“We’re fundamentally a software company,” Locus CEO Rick Faulk says with a laugh. We look like a robot company, but we’re actually a software company.” It’s a familiar refrain from companies whose ...
In psychology, it’s almost universally accepted that we want people to have an internal locus of control. The alternative? An external locus of control. Source: Photo by Milad Fakurian on Unsplash ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. As Mother Teresa famously said, "To work without love is slavery." She was speaking about ...
The last few years have been a major accelerator for the robotics industry at large, but warehouse robotics may be the biggest winner of all. Stay at home orders fueled adoption in the early days of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback